Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) -15.97-16.8858.1714.65-4.72

What is the latest EV/Core EBITDA ratio of OXYGENTA PHARMACEUTICAL ?

The latest EV/Core EBITDA ratio of OXYGENTA PHARMACEUTICAL is -15.97 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar2024-15.97
Mar2023-16.88
Mar202258.17
Mar202114.65
Mar2020-4.72

How is EV/Core EBITDA of OXYGENTA PHARMACEUTICAL Trending?

Years EV/Core EBITDA % Change
Mar2024 -15.97
Negative
Mar2023 -16.88
Negative
Mar2022 58.17
297.06
Mar2021 14.65
Positive
Mar2020 -4.72 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare EV/Core EBITDA ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹314.7 Cr 10.5% 8.3% 111.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,725.0 Cr 2.5% 0.2% 17.2% Stock Analytics
DIVIS LABORATORIES ₹159,525.0 Cr 2.1% 3.7% 66.4% Stock Analytics
CIPLA ₹123,206.0 Cr 0.9% 0.1% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,519.0 Cr -0.6% 0.4% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,927.5 Cr -0.3% -2.2% -0.1% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

10.5%

8.3%

111.2%

SENSEX

0.8%

3.8%

8.4%


You may also like the below Video Courses